At the intersection of health and the climate is an urgent crisis. This crisis affects health in ways that are wide-ranging, ...

Antimicrobial resistance (AMR) is an urgent global health crisis. AMR infections cause an estimated 1.3 million deaths globally every year, and this number is only projected to rise.

In this report, we investigate the theory and practice of value-based pricing in the pharmaceuticals industry, and provide recommendations for how implementation of value-based pricing can be enhanced ...

For the growing number of multi-indication medicines, access may be delayed or even denied due to challenges in linking payment with a medicine’s value across those indications. We assembled a broad ...

This report examines the importance and history of HTA evaluations for additional uses for cancer drugs after their initial approval. Included are the ten cancer drugs approved by the EMA during ...

A biennial prize fund to promote thought leadership around the big questions affecting health economics. OHE’s educational mission is to support, sustain, and enhance the discipline of health ...

Earlier today, the UK government unveiled the long-awaited NHS Ten Year Plan. Commenting on the Plan, Professor Graham Cookson, Chief Executive of the Office of Health Economics, said: “The hotly ...

US drug pricing policies will have global impacts on innovation and access The knowledge generated through biomedical innovation is a public good. One person’s use does not reduce its availability to ...

With the new NHS 10-Year Plan now published, attention turns from ambition to action. How realistic is the roadmap? What will it take to deliver meaningful change in the face of economic constraints, ...

Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised.

The US spends significantly more on healthcare per person than other wealthy countries. H.R. 3 is a recent policy proposal aimed at reducing national spending on prescription drugs, one component of ...